Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Biol Res ; 57(1): 69, 2024 Sep 28.
Artículo en Inglés | MEDLINE | ID: mdl-39342392

RESUMEN

BACKGROUND: The LYP tyrosine phosphatase presents a SNP (1858C > T) that increases the risk of developing autoimmune diseases such as type I diabetes and arthritis. It remains unclear how this SNP affects LYP function and promotes the development of these diseases. The scarce information about LYP substrates is in part responsible for the poor understanding of LYP function. RESULTS: In this study, we identify in T lymphocytes several adaptor proteins as potential substrates targeted by LYP, including FYB, SLP-76, HS-1, Vav, SKAP1 and SKAP2. We also show that LYP co-localizes with SLP76 in microclusters, upon TCR engagement. CONCLUSIONS: These data indicate that LYP may modulate T cell activation by dephosphorylating several adaptor proteins, such as FYB, SLP-76, HS-1, Vav, SKAP1 and SKAP2 upon TCR engagement.


Asunto(s)
Proteínas Adaptadoras Transductoras de Señales , Fosfoproteínas , Proteína Asociada a la Molécula de Señalización de la Activación Linfocitaria , Linfocitos T , Humanos , Proteínas Adaptadoras Transductoras de Señales/metabolismo , Células Jurkat , Activación de Linfocitos , Fosfoproteínas/metabolismo , Fosforilación , Proteínas Tirosina Fosfatasas/metabolismo , Receptores de Antígenos de Linfocitos T/metabolismo , Linfocitos T/metabolismo , Proteína Asociada a la Molécula de Señalización de la Activación Linfocitaria/genética , Proteína Asociada a la Molécula de Señalización de la Activación Linfocitaria/metabolismo
2.
Trends Immunol ; 26(1): 48-55, 2005 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-15629409

RESUMEN

Antigen-antibody complexes can damage tissues by triggering inflammation. Recent studies have enabled the description of a sequence of steps, which depend on the intra- or perivascular location of complex formation. Acute lethal toxicity and circulatory shock as a result of the acute release of inflammatory mediators can occur after intravascular complex formation. The lesions associated with perivascular complexes are characterized by plasma leakage and the recruitment of polymorphonuclear leukocytes. These lesions are modulated by mediators released from endothelial cells, namely nitric oxide, endothelins and lipid mediators, and provide an appropriate basis for the activation of both arms of hemostasis: coagulation and fibrinolysis. The balance between both activation systems can explain the late occurrence of both tissue fibrosis and organ remodeling.


Asunto(s)
Complejo Antígeno-Anticuerpo/inmunología , Endotelio Vascular/inmunología , Enfermedades del Complejo Inmune/inmunología , Animales , Complejo Antígeno-Anticuerpo/efectos adversos , Endotelio Vascular/patología , Fibrosis , Humanos , Enfermedades del Complejo Inmune/patología , Modelos Biológicos , Receptores Fc/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA